Richard Crowley, EVP, Biopharmaceutical Operations at SAVIENT PHARMACEUTICALS INC (SVNT), sold 48,900 shares at $1.01 ($51K) on 2013-02-04, disclosed to the SEC on 2013-02-06.
Scheduled sale ($51k) by EVP, Biopharmaceutical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.01 | 18,900 | $19K | 37.7% |
| 2 | $1.05 | 30,000 | $32K | 62.3% |
| Total | $1.03 avg | 48,900 | $51K | 100% |
| Filing → |
| SVNT | SELL | 2013-02-04 | $2K | — | Filing → |
| SVNT | SELL | 2012-11-06 | $3K | — | Filing → |
| SVNT | SELL | 2012-08-03 | $2K | — | Filing → |